Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for NYU Langone Hospital - Brooklyn located at 150 55Th St, Brooklyn, NY, 11220 & includes data from NPIs 1811936529, 1538111653, 1346614443, 1437523537, 1528432622, 1528013695, 1619341716
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark 30 Day readmissions outcomes for NYU Langone Hospital - Brooklyn compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,221 | 1,159 | ||||||||||
| Surgical | 270 | 262 | ||||||||||
| Non Surgical | 951 | 897 | ||||||||||
| General Medicine | 212 | 195 | ||||||||||
| Cardiovascular | 190 | 177 | ||||||||||
| Orthopedics | 133 | 129 | ||||||||||
| Urology | 132 | 128 | ||||||||||
| Gastroenterology & Endocrinology | 124 | 119 | ||||||||||
| Neurology | 117 | 114 | ||||||||||
| General Surgery | 95 | 92 | ||||||||||
| Pulmonology | 88 | 84 | ||||||||||
| Psychiatry & Mental Disorders | 50 | 47 | ||||||||||
| Oncology & Hematology | 47 | 44 | ||||||||||
| Dermatology | 15 | 13 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Diabetes |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory Neoplasms |